Carmignac Portfolio Long Short European Equities: Letter from the Fund Manager
![[Management Team] [Author] Heininger Malte](https://carmignac.imgix.net/uploads/NextImage/0001/18/%5BManagement-Team%5D-Heiniger-Malte.png?auto=format%2Ccompress&fit=fill&w=3840)
Dear investors,
Our fund delivered a quarterly performance of -2.26%, in the F EUR share class, net of fees, while the year-to-date performance stands at +16.54% at the end of September.
Despite the negative performance for the quarter, the portfolio benefited from strong contributions from both our Long and Short ideas.
On the long side, our core positions in SAP and Meta, and our trading positions in Deutsche Telekom and Fresenius performed well with strong Q2 numbers and positive earnings momentum.
Our short positions suffered from the sudden market recovery, particularly our Tech shorts like Salesforce and Micron. At the same time, our Core Long position in Nova showed poor performance being down around 11% after two strong quarters at the beginning of the year.
The Carmignac Portfolio Long Short European Equities strategy attributions by bucket were:
| Core Longs | -3.19 | +21.33 |
| Trading Longs | +2.78 | +5.06 |
| Relative Value/Special Sit | +0.05 | +0.21 |
| Alpha Shorts | -3.23 | -2.89 |
| Hedging | +0.04 | -4.25 |
Q3 was a very volatile quarter. While most markets ended the quarter higher, the headline numbers masked some massive turmoil intra-quarter. The SOX dropped 25% from its July peak, the Nasdaq had an almost 14% pullback and the European market had a close to 10% correction. Meanwhile, the Topix dropped 12% in a day in early August, while the VIX hit its March 2020 highs.
While the strategy gave back some gains in early July after a very strong June, the second half of July and the month of August were positive. The reason for our portfolio's pullback early July was mainly led by our semiconductor positions. We started the year with a fairly constructive view on the sector, as the industry was coming out of a severe downturn with several structural and cyclical tailwinds, which gave us some constructive views on several parts of the value chain.
As the year progressed, there started to appear cracks in many aspects of the bull case, particularly for the wafer fab equipment players. Firstly, the expected second half cyclical recovery of the traditional semiconductor business did not materialize. The sector experienced continued weakness and inventory built in the automotive, industrial, PC & Mobile end markets. Secondly, following these first signs of cracks appearing in the sector, delays started to appear on many of the politically driven mega fab projects due to supply chain issues, staff shortages, planning delays, etc.
Furthermore, the technological issues of both Intel & Samsung (2nd & 3rd largest capex spenders) started to become more apparent, with both firms struggling with the note transition and severe technological shortcomings that led to capex cuts. Lastly, we saw a lot of the slack of demand for semiconductor equipment being picked-up by China, which accounted for close to 50% of sales for many of the large equipment companies in Q2. This level was unsustainable and driven by hording and a potentially risky customer base, due to increased political tensions and the potential for further export controls. We exited most of our semiconductor exposure in early July for these reasons.
That said, we remain excited about the prospects of artificial intelligence (AI) and we like to keep some exposure to the theme, but effectively it is a fairly narrow part of the industry and a limited number of players benefit from it, namely the GPU & Datacentre space. However, we see big dispersion between the winners and the losers, while many other parts of the sector are struggling for various reasons.
The overall book is fairly defensively positioned right now with most of our large Longs in the Software, Healthcare, Insurance and Telecommunications sectors where we find many attractive, company specific opportunities. Looking at the earnings trajectories and the performance of many of the popular European blue chips, the picture is not very encouraging and there were many pitfalls. Nestle hit a new multi-year low and is down 30% from the peak, LVMH is down 30% from last year’s highs, ASML dropped 35% since the summer, L’Oreal is down more than 20% since Q2 and Novo Nordisk had a 25% pullback since Q2 as well.
Overall, we consider the market attractive from a strong stock picking perspective with significant amount of dispersion and a great idea flow on both longs and shorts.
Carmignac Portfolio Long-Short European Equities
A high-conviction long/short approach to European equitiesDiscover the fund pageCarmignac Portfolio Long-Short European Equities F EUR Acc
- Recommended minimum investment horizon
- 3 years
- Risk indicator*
- 3/7
- SFDR - Fund Classification**
- Article 8
*Risk Scale from the KID (Key Information Document). Risk 1 does not mean a risk-free investment. This indicator may change over time. **The Sustainable Finance Disclosure Regulation (SFDR) 2019/2088 is a European regulation that requires asset managers to classify their funds as either 'Article 8' funds, which promote environmental and social characteristics, 'Article 9' funds, which make sustainable investments with measurable objectives, or 'Article 6' funds, which do not necessarily have a sustainability objective. For more information please refer to https://eur-lex.europa.eu/eli/reg/2019/2088/oj.
Main risks of the fund
Fees
- Entry costs
- We do not charge an entry fee.
- Exit costs
- We do not charge an exit fee for this product.
- Management fees and other administrative or operating costs
- 1,16% of the value of your investment per year. This estimate is based on actual costs over the past year.
- Performance fees
- 20,00% max. of the outperformance if the performance is positive and the net asset value exceeds the high-water mark. The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years, or since the product creation if it is less than 5 years.
- Transaction Cost
- 0,83% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the investments underlying the product. The actual amount varies depending on the quantity we buy and sell.
Performance
| Carmignac Portfolio Long-Short European Equities | 2.3 | -7.7 | 10.0 | 16.7 | 5.1 | 0.3 | 7.4 | 13.6 | -5.7 | 0.7 |
| Carmignac Portfolio Long-Short European Equities | + 2.8 % | + 7.7 % | + 5.7 % |
Source: Carmignac at 31 Oct 2024.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor).
Related articles
Our Merger Arbitrage strategies win ‘Best new launch’ award
Best ESG Alternative Fund award goes to Carmignac
Marketing communication. Please refer to the KID/KIID, prospectus of the fund before making any final investment decisions. This document is intended for professional clients.
This material may not be reproduced, in whole or in part, without prior authorisation from the Management Company. This material does not constitute a subscription offer, nor does it constitute investment advice. This material is not intended to provide, and should not be relied on for, accounting, legal or tax advice. This material has been provided to you for informational purposes only and may not be relied upon by you in evaluating the merits of investing in any securities or interests referred to herein or for any other purposes. The information contained in this material may be partial information and may be modified without prior notice. They are expressed as of the date of writing and are derived from proprietary and non-proprietary sources deemed by Carmignac to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by Carmignac, its officers, employees or agents.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice. The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
Morningstar Rating™ : © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Access to the Funds may be subject to restrictions regarding certain persons or countries. This material is not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the material or availability of this material is prohibited. Persons in respect of whom such prohibitions apply must not access this material. Taxation depends on the situation of the individual. The Funds are not registered for retail distribution in Asia, in Japan, in North America, nor are they registered in South America. Carmignac Funds are registered in Singapore as restricted foreign scheme (for professional clients only). The Funds have not been registered under the US Securities Act of 1933. The Funds may not be offered or sold, directly or indirectly, for the benefit or on behalf of a «U.S. person», according to the definition of the US Regulation S and FATCA.
The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital.
The Funds’ prospectus, KIDs, NAVs and annual reports are available at www.carmignac.com, or upon request to the Management Carmignac Portfolio refers to the sub-funds of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive. The French investment funds (fonds communs de placement or FCP) are common funds in contractual form conforming to the UCITS or AIFM Directive under French law.
In France, Luxembourg, Sweden: The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital. The Funds’ prospectus, KIDs, NAV and annual reports are available at www.carmignac.com, or upon request to the Management.
In the United Kingdom: the Funds’ respective prospectuses, KIIDs and annual reports are available at www.carmignac.co.uk, or upon request to the Management Company, or for the French Funds, at the offices of the Facilities Agent at BNP PARIBAS SECURITIES SERVICES, operating through its branch in London: 55 Moorgate, London EC2R. This document was prepared by Carmignac Gestion, Carmignac Gestion Luxembourg or Carmignac UK Ltd. FP Carmignac ICVC (the “Company”) is an Investment Company with variable capital incorporated in England and Wales under registered number 839620 and is authorised by the FCA with effect from 4 April 2019 and launched on 15 May 2019. FundRock Partners Limited is the Authorised Corporate Director (the “ACD”) of the Company and is authorised and regulated by the FCA. Registered Office: Hamilton Centre, Rodney Way, Chelmsford, Essex, CM1 3BY, UK; Registered in England and Wales with number 4162989. Carmignac Gestion Luxembourg SA has been appointed as the Investment Manager and distributor in respect of the Company. Carmignac UK Ltd (Registered in England and Wales with number 14162894) has been appointed as a sub-Investment Manager of the Company and is authorised and regulated by the Financial Conduct Authority with FRN:984288.
In Switzerland: the prospectus, KIDs and annual report are available at www.carmignac.ch, or through our representative in Switzerland, CACEIS (Switzerland), S.A., Route de Signy 35, CH-1260 Nyon. The paying agent is CACEIS Bank, Montrouge, Nyon Branch / Switzerland, Route de Signy 35, 1260 Nyon.
The Management Company can cease promotion in your country anytime.
Investors have access to a summary of their rights in English on the following links: UK ; Switzerland ; France ; Luxembourg ; Sweden.